Life is a health journey and we, at Sanofi, hope to make a difference in the lives of people affected by immune disorders by developing innovative therapies. Immune disorders are diseases or conditions caused by a dysfunction of the immune system and include allergy, asthma and autoimmune diseases.
As a health journey partner, we are dedicated to bringing new options to patients with an unmet need. In collaboration with Regeneron Pharmaceuticals, our current therapies for atopic dermatitis and rheumatoid arthritis are approved in the United States, Canada and Europe and we are seeking approvals in a number of countries globally.
Current research conducted by Sanofi Genzyme, our global specialty care business unit, includes investigational treatments for asthma, nasal polyps, and eosinophilic esophagitis, each of which represent an area of significant need including those in emerging markets.(1).
(1)Emerging markets: world excluding U.S., Canada, Western Europe (France, Germany, UK, Italy, Spain, Greece, Cyprus, Malta, Belgium, Luxembourg, Portugal, the Netherlands, Austria, Switzerland, Sweden, Ireland, Finland, Norway, Iceland, Denmark), Japan, South Korea, Australia and New Zealand.